In new data from a phase 2 dose-ranging trial, researchers found weight loss continued to increase up to 13 weeks for adults with overweight or obesity
Bning Journal: Molecular therapy : the journal of the American Society of Gene Therapy Journal ranking: Q1 Key takeaways: Tropism-modified AAV vectors with novel receptors significantly improve cutaneous gene therapy by increasing cell entry efficiency and targeting v8 integrin, overcoming safety concerns.
Clinically, GLP-1 agonists appear to have a broadly beneficial impact on cancer prevention as supported by this report
Jung, Y.-H., Kim, H., Kim, H., Kim, E., Baik, J., & Kang, H
Step 5: Swirl gently